Kelly Dinnan, DO
Surgery · Glendive, MTNPI 1841405891
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,872 of the $2,965 with a category attached, or 63.1%. 17 manufacturers reported payments, led by Kls-martin L.p. at 41.6% of the total. That places this record below the midpoint for surgery clinicians in MT, where the typical reported total is $2,656.
Across 47 payments — averaging $63.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$1K
- Medtronic$1K
- CSL Behring$133
- Davol Inc.$93
- TELA Bio, Inc.$61
- Smith+Nephew$50
- plus $302 from 11 others
What the payments were for
- Travel & lodging$1,87263%
- Food & beverage$84328%
- Education$2508%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 5 | $1,235 |
| Medtronic | 10 | $1,090 |
| CSL Behring | 7 | $133 |
| Davol Inc. | 1 | $93 |
| TELA Bio, Inc. | 4 | $61 |
| Smith+Nephew | 3 | $50 |
| Boston Scientific | 3 | $47 |
| Braintree Laboratories, Inc. | 3 | $43 |
| Covidien LP | 2 | $40 |
| Acelrx Pharmaceuticals, Inc. | 2 | $40 |
| La Jolla Pharmaceutical Company | 1 | $25 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Z-medica, LLC | 1 | $20 |
| Polarityte, Inc. | 1 | $20 |
| Edwards Lifesciences | 1 | $18 |
| Teleflex LLC | 1 | $15 |
| Bard Peripheral Vascular, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LigaSure$827
How this compares
$2,965 in reported general payments places this provider in the 50th percentile of 96 surgery providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 11 | $386 |
| Omeprazole | 18 | $116 |
| Famotidine | 14 | $80 |
Paid to pharmacies, not to this prescriber.
Other surgery in Glendive
- John MeansKalispell$72K
- Matthew SilvaMissoula$59K
- Michael WilcoxBillings$45K
- James CromieKalispell$35K
- Jacob OpferBozeman$29K
- Bret MurrayBillings$27K
- Ryan GunliksonWhitefish$26K
- Emily BubbersHelena$23K
- Katie DawsonButte$22K
- Robin HapeBozeman$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.